KAS
ALT icon

Kestra Advisory Services’s Altimmune ALT Stock Holding History

Kestra Advisory Services’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,682
Closed -$113K – 2756
2024
Q4 		$113K Buy
15,682
+2,572
+20% +$19.6K ﹤0.01% 2561
2024
Q3 		$80.5K Buy
13,110
+1,131
+9% +$7.66K ﹤0.01% 2484
2024
Q2 		$79.7K Buy
+11,979
New +$88.4K ﹤0.01% 2537

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kestra Advisory Services's ALT Position: Q1 2025 in Review

Kestra Advisory Services sold out of Altimmune (ALT) in Q1 2025, closing a stake of 15,682 shares — an estimated $113K sold.

Kestra Advisory Services first reported a position in ALT in Q2 2024 and held it in 3 quarters. The position peaked at $113K in Q4 2024. 176 funds tracked by Wall St. Rank hold ALT as of Q1 2025.

  • Kestra Advisory Services reported no remaining Altimmune position as of Q1 2025 after selling out during the quarter.
  • Kestra Advisory Services sold 15,682 Altimmune shares in Q1 2025, an estimated $113K.
  • Kestra Advisory Services first reported a position in Altimmune in Q2 2024 and held it in 3 quarters.
  • Kestra Advisory Services's Altimmune position peaked at $113K in Q4 2024.
  • 176 funds tracked by Wall St. Rank held Altimmune as of Q1 2025.

Based on Kestra Advisory Services's 13F filing for Q1 2025, filed 14 May 2025.